Gene Signature Identifies Breast Cancer Patients Who Will Respond To Chemotherapy

[News]

Researchers have identified a genetic signature that can predict which breast cancer patients will respond well to treatment with epirubicin, a widely used form of chemotherapy. Although among the most effective chemotherapies in breast cancer, a small proportion of women suffer severe side-effects. By identifying those women who are most likely to benefit from treatment, doctors may be able to ensure fewer women are unnecessarily exposed to that risk.

More... (http://www.medicalnewstoday.com/articles/150066.php)